These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 490684)
21. 2,3-Dimercaptopropane-1-sodium sulfonate for reducing retention of ingested 203Hg in suckling rats. Kostial K; Kargacin B; Landeka M Bull Environ Contam Toxicol; 1988 Aug; 41(2):185-8. PubMed ID: 3207899 [No Abstract] [Full Text] [Related]
22. The therapeutic use of 2,3-dimercaptopropane-1-sulfonate in two cases of inorganic mercury poisoning. Campbell JR; Clarkson TW; Omar MD JAMA; 1986 Dec; 256(22):3127-30. PubMed ID: 3783847 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of 14C-DMPS (sodium-1,3 14C-2,3-dimercaptopropane-1-sulphonate) in beagle dogs. Wiedemann P; Fichtl B; Szinicz L Biopharm Drug Dispos; 1982; 3(3):267-74. PubMed ID: 7139066 [TBL] [Abstract][Full Text] [Related]
24. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate. Aposhian HV; Arroyo A; Cebrian ME; del Razo LM; Hurlbut KM; Dart RC; Gonzalez-Ramirez D; Kreppel H; Speisky H; Smith A; Gonsebatt ME; Ostrosky-Wegman P; Aposhian MM J Pharmacol Exp Ther; 1997 Jul; 282(1):192-200. PubMed ID: 9223554 [TBL] [Abstract][Full Text] [Related]
25. Interactions of the chelating agent 2,3-dimercaptopropane-1-sulfonate with red blood cells in vitro. II. Effects on metalloproteins. Reuther H; Wildenauer DB; Weger N Chem Biol Interact; 1982 Nov; 42(2):179-94. PubMed ID: 6817929 [TBL] [Abstract][Full Text] [Related]
26. Biological behavior and metabolic fate of the BAL analogues DMSA and DMPS. McGown EL; Tillotson JA; Knudsen JJ; Dumlao CR Proc West Pharmacol Soc; 1984; 27():169-76. PubMed ID: 6093126 [No Abstract] [Full Text] [Related]
27. Copper, zinc, and selenium in human blood and urine after injection of sodium 2,3-dimercaptopropane-1-sulfonate: a study on subjects with dental amalgam. Høl PJ; Vamnes JS; Gjerdet NR; Eide R; Isrenn R Biol Trace Elem Res; 2003 Jan; 91(1):19-31. PubMed ID: 12713026 [TBL] [Abstract][Full Text] [Related]
28. Subchronic treatment with sodium 2,3-dimercaptopropane-1-sulfonate in methylmercury poisoning. Schäfer SG; Storp M; Richter E Bull Environ Contam Toxicol; 1982 Oct; 29(4):416-21. PubMed ID: 7171852 [No Abstract] [Full Text] [Related]
29. Chelation in metal intoxication. XX: Effect of pre-treatment with chelators on the distribution of mercury. Kachru DN; Tandon SK Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):399-402. PubMed ID: 3016847 [TBL] [Abstract][Full Text] [Related]
30. Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. Garza-Ocañas L; Torres-Alanís O; Piñeyro-López A J Toxicol Clin Toxicol; 1997; 35(6):653-5. PubMed ID: 9365436 [TBL] [Abstract][Full Text] [Related]
31. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. Gonzalez-Ramirez D; Maiorino RM; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Aposhian MM; Dart RC; Diaz Gama JH; Echeverria D J Pharmacol Exp Ther; 1995 Jan; 272(1):264-74. PubMed ID: 7815341 [TBL] [Abstract][Full Text] [Related]
32. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats. Juresa D; Blanusa M; Kostial K Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364 [TBL] [Abstract][Full Text] [Related]
33. Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. Van der Linde AA; Pillen S; Gerrits GP; Bouwes Bavinck JN Clin Toxicol (Phila); 2008 Jun; 46(5):479-81. PubMed ID: 18568806 [TBL] [Abstract][Full Text] [Related]
34. Influence of 2,3-dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the mobilization of mercury from tissues of rats pretreated with mercuric chloride, phenylmercury acetate or mercury vapors. Buchet JP; Lauwerys RR Toxicology; 1989 Mar; 54(3):323-33. PubMed ID: 2539660 [TBL] [Abstract][Full Text] [Related]
35. Effects of repeated treatment with sodium 2,3-dimercaptopropane-1-sulfonate in beagle dogs. Szinicz L; Wiedemann P; Häring H; Weger N Arzneimittelforschung; 1983; 33(6):818-21. PubMed ID: 6684434 [No Abstract] [Full Text] [Related]
36. [Control of trace elements in the rat using the heavy metal antidote "Unithiol" (sodium-2,3- dimercaptopropane sulfonate)]. Golbs S; Fuchs V; Pfüller U; Ebert E; Pfeifer D Arch Exp Veterinarmed; 1980; 34(3):373-81. PubMed ID: 7436672 [TBL] [Abstract][Full Text] [Related]
37. Chelation in metal intoxication. XV: Influence of dimercaptopropane sulphonate (DMPS) on lead poisoned rats with normal or damaged kidneys. Flora SS; Tandon SK Ind Health; 1985; 23(1):17-24. PubMed ID: 3997563 [No Abstract] [Full Text] [Related]
38. Antagonism of acute copper(II)-induced renal lesions by sodium 2,3-dimercaptopropanesulfonate. Mitchell WM; Basinger MA; Jones MM Johns Hopkins Med J; 1982 Dec; 151(6):283-5. PubMed ID: 7176288 [TBL] [Abstract][Full Text] [Related]
39. [DMSP treatment in acute sublimate (mercury chloride) poisoning]. Nadig J; Knutti R; Hany A Schweiz Med Wochenschr; 1985 Apr; 115(15):507-11. PubMed ID: 3992234 [TBL] [Abstract][Full Text] [Related]
40. Toxicological studies on sodium 2,3-dimercaptopropane-1-sulfonate in the rat. Planas-Bohne F; Gabard B; Schäffer EH Arzneimittelforschung; 1980; 30(8):1291-4. PubMed ID: 7192144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]